InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

- Current share price for RHY : $0.088

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$31 Change of Director's Interest Notice - Trevor Lockett 7 Aug 2024 11:43AM $0.048 $0.088 risen by 83.33%
$31 Notification of cessation of securities - RHY 1 Aug 2024 9:40AM $0.053 $0.088 risen by 66.04%
$31 Jun 24 Quarterly Activities Report and Appendix 4C 29 Jul 2024 9:30AM $0.056 $0.088 risen by 57.14%
$31 Bioshares Biotech Summit Presentation 12 Jul 2024 4:14PM $0.060 $0.088 risen by 46.67%
$31 Close of Shortfall Offer Pursuant to the Rights Issue 17 Jun 2024 9:40AM $0.066 $0.088 risen by 33.33%
$31 Change of Director's Interest Notice - Otto Buttula 17 Jun 2024 9:31AM $0.066 $0.088 risen by 33.33%
$31 Change of Director's Interest - Otto Buttula 4 Jun 2024 10:00AM $0.071 $0.088 risen by 23.94%
$31 Change of Director's Interest Notice - Otto Buttula 28 May 2024 9:29AM $0.070 $0.088 risen by 25.71%
$31 Cancel - Notification regarding unquoted securities - RHY 27 May 2024 6:51PM $0.070 $0.088 risen by 25.71%
$31 Notification regarding unquoted securities - RHY 27 May 2024 6:00PM $0.070 $0.088 risen by 25.71%
$31 Notification regarding unquoted securities - RHY 27 May 2024 9:43AM $0.069 $0.088 risen by 27.54%
$31 Notification regarding unquoted securities - RHY 27 May 2024 9:40AM $0.069 $0.088 risen by 27.54%
$31 Otto Buttula to revert back to Non-Executive Chair 22 May 2024 9:24AM $0.068 $0.088 risen by 29.41%
$31 Application for quotation of securities - RHY 7 May 2024 10:43AM $0.081 $0.088 risen by 8.64%
$31 Mar24 Quarterly Activities Report and Appendix 4C 30 Apr 2024 9:09AM $0.081 $0.088 risen by 8.64%
$31 Dr David Atkins appointed Chief Executive Officer of Rhythm 24 Apr 2024 11:20AM $0.088 $0.088 fallen by 0%
$31 Rhythm Maintains ISO Certification 23 Apr 2024 9:27AM $0.088 $0.088 fallen by 0%
$31 Change in substantial holding - Otto Buttula 2 Apr 2024 9:43AM $0.095 $0.088 fallen by 7.37%
$31 Change of Director's Interest Notice - Trevor Lockett 27 Mar 2024 8:38AM $0.093 $0.088 fallen by 5.38%
$31 Change of Director's Interest Notice - Lou Panaccio 27 Mar 2024 8:38AM $0.093 $0.088 fallen by 5.38%
$31 Change of Director's Interest Notice - Otto Buttula 27 Mar 2024 8:37AM $0.093 $0.088 fallen by 5.38%
$31 Ceasing to be a substantial holder 25 Mar 2024 2:23PM $0.093 $0.088 fallen by 5.38%
$31 Distribution schedule - RHYO options 21 Mar 2024 11:01AM $0.097 $0.088 fallen by 9.28%
$31 Top 20 securityholders - RHYO options 21 Mar 2024 11:00AM $0.097 $0.088 fallen by 9.28%
$31 Update - Application for quotation of securities - RHY 21 Mar 2024 10:56AM $0.097 $0.088 fallen by 9.28%

201 - 225 of 641 results

Page 9 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.